You didn't answer the question.
It's a box that needs to be ticked, I never said it was unnecessary. They need to be able to manufacture safely.
But how does it improve the likelihood that the FDA will be convinced of the data regarding the efficacy of the cells?
Should be an easy answer, since you are so convinced.
Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-43
-
- There are more pages in this discussion • 320 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.015(1.49%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.02 | 99.5¢ | $2.005M | 1.991M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14424 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 63643 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |